BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17910966)

  • 1. Pharmacokinetics of disodium-fosfomycin in mongrel dogs.
    Gutierrez OL; Ocampo CL; Aguilera JR; Luna J; Sumano LH
    Res Vet Sci; 2008 Aug; 85(1):156-61. PubMed ID: 17910966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses.
    Zozaya DH; Gutiérrez OL; Ocampo CL; Sumano LH
    J Vet Pharmacol Ther; 2008 Aug; 31(4):321-7. PubMed ID: 18638292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous and intramuscular pharmacokinetics of a single-daily dose of disodium-fosfomycin in cattle, administered for 3 days.
    Sumano LH; Ocampo CL; Gutierrez OL
    J Vet Pharmacol Ther; 2007 Feb; 30(1):49-54. PubMed ID: 17217401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disodium-fosfomycin pharmacokinetics and bioavailability in post weaning piglets.
    Soraci AL; Perez DS; Martinez G; Dieguez S; Tapia MO; Amanto F; Harkes R; Romano O
    Res Vet Sci; 2011 Jun; 90(3):498-502. PubMed ID: 20696447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of cefovecin in dogs.
    Stegemann MR; Sherington J; Blanchflower S
    J Vet Pharmacol Ther; 2006 Dec; 29(6):501-11. PubMed ID: 17083454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.
    Pfausler B; Spiss H; Dittrich P; Zeitlinger M; Schmutzhard E; Joukhadar C
    J Antimicrob Chemother; 2004 May; 53(5):848-52. PubMed ID: 15056646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing pharmacokinetics of different doses of fosfomycin in laboratory rats enables adequate exposure for pharmacodynamic models.
    Poeppl W; Lingscheid T; Bernitzky D; Donath O; Reznicek G; Zeitlinger M; Burgmann H
    Pharmacology; 2014; 93(1-2):65-8. PubMed ID: 24503567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs.
    Vanapalli SR; Hung YP; Fleckenstein L; Dzimianski MT; McCall JW
    Biopharm Drug Dispos; 2002 Oct; 23(7):263-72. PubMed ID: 12355577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.
    Gattringer R; Meyer B; Heinz G; Guttmann C; Zeitlinger M; Joukhadar C; Dittrich P; Thalhammer F
    J Antimicrob Chemother; 2006 Aug; 58(2):367-71. PubMed ID: 16782745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats.
    Albarellos GA; Ambros LA; Landoni MF
    Vet J; 2008 Nov; 178(2):238-43. PubMed ID: 17768077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs.
    KuKanich B; Coetzee JF
    J Vet Pharmacol Ther; 2008 Apr; 31(2):102-7. PubMed ID: 18307501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.
    Roussos N; Karageorgopoulos DE; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2009 Dec; 34(6):506-15. PubMed ID: 19828298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration.
    Aramayona JJ; Bregante MA; Solans C; Rueda S; Fraile LJ; Garcia MA
    Vet Res; 1997; 28(6):581-8. PubMed ID: 9428152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of florfenicol after intravenous and intramuscular administration in New Zealand White rabbits.
    Koc F; Ozturk M; Kadioglu Y; Dogan E; Yanmaz LE; Okumus Z
    Res Vet Sci; 2009 Aug; 87(1):102-5. PubMed ID: 19062054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep.
    Cárceles CM; Escudero E; Fernández-Varón E; Marín P
    Vet J; 2009 Jun; 180(3):343-7. PubMed ID: 18406644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
    Boothe DM; Perkins J
    J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular concentrations of fosfomycin in lung tissue of septic patients.
    Matzi V; Lindenmann J; Porubsky C; Kugler SA; Maier A; Dittrich P; Smolle-Jüttner FM; Joukhadar C
    J Antimicrob Chemother; 2010 May; 65(5):995-8. PubMed ID: 20228081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.